Last Updated: May 3, 2026

LIDOCAINE HYDROCHLORIDE W Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Lidocaine Hydrochloride W patents expire, and what generic alternatives are available?

Lidocaine Hydrochloride W is a drug marketed by Abbott, Bel Mar, Dell Labs, Intl Medication, and Watson Labs. and is included in eight NDAs.

The generic ingredient in LIDOCAINE HYDROCHLORIDE W is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for LIDOCAINE HYDROCHLORIDE W?
What are the global sales for LIDOCAINE HYDROCHLORIDE W?
What is Average Wholesale Price for LIDOCAINE HYDROCHLORIDE W?

Summary for LIDOCAINE HYDROCHLORIDE W

US Patents:	0
Applicants:	5
NDAs:	8

US Patents and Regulatory Information for LIDOCAINE HYDROCHLORIDE W

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbott	LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE	epinephrine; lidocaine hydrochloride	INJECTABLE;INJECTION	083154-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Watson Labs	LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE	epinephrine; lidocaine hydrochloride	INJECTABLE;INJECTION	080377-003	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Dell Labs	LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE	epinephrine; lidocaine hydrochloride	INJECTABLE;INJECTION	083389-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Watson Labs	LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE	epinephrine; lidocaine hydrochloride	INJECTABLE;INJECTION	085463-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Bel Mar	LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE	epinephrine; lidocaine hydrochloride	INJECTABLE;INJECTION	080820-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.